OSCO serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry.
Pharmacyclics invites OSCO members to their Product Theatre program discussing IMBRUVICA® (ibrutinib) during the Society of Hematologic Oncology’s Annual Conference in Houston Texas. See Details in the Invite Below and click on this link to register: Product Theatre Registration Additional information about SOHO is available at their website SOHO 2022 Annual Meeting.
Read More...The US Food and Drug Administration (FDA) has approved a new indication for IMFINZI® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC).1 BTCs comprise a heterogeneous group of rare cancers, including intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder cancer, that account for approximately 1% of all new cancer cases annually in the United […]
Read More...Thanks to @SenatorLankford, the Medicare #MCED Screening Coverage Act now has 51 cosponsors in the Senate! This bill is a must-pass for Oklahoma seniors, who deserve to access the best possible tools to detect cancer early.
Read More...Join the Oklahoma Society of Clinical Oncology, Inc. for our fall meeting on November 6, 2021, ASCO Direct™, an officially licensed program of the American Society of Clinical Oncology®. This virtual meeting will break down the most clinically relevant abstracts from ASCO’s annual symposium, allowing attendees to engage with the latest strategies in oncology education. All exhibitors will have access to the full meeting application and will be able to view all the virtual sessions. Details of the virtual meeting are:
Your company can sponsor OSCO and the work we do by becoming a corporate member today! For more information or to sign up, contact Kathy Musson, OSCO Executive Director at kmussonokc@gmail.com or by phone at 405-850-8334.
The Oklahoma Society of Clinical Oncology (OSCO) is Oklahoma’s only professional organization that represents all those in oncology. Our membership works to advance the sciences of hematology and oncology and its sub-specialties, and to improve services to the public by studying the socio-economic aspects of the practice of our members.
